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ABSTRACT
The RPM2 gene of Saccharomyces cerevisiae codes
for a protein subunit of mitochondrial RNase P
and has another unknown essential function.
We previously demonstrated that Rpm2p localizes
to the nucleus and acts as a transcriptional
activator. Rpm2p influences the level of mRNAs
that encode components of the mitochondrial
import apparatus and essential mitochondrial
chaperones. Evidence is presented here that
Rpm2p interacts with Dcp2p, a subunit of mRNA
decapping enzyme in the two-hybrid assay, and is
enriched in cytoplasmic P bodies, the sites of mRNA
degradation and storage in yeast and mammalian
cells. When overexpressed, GFP-Rpm2p does not
impact the number and size of P bodies; however,
it prevents their disappearance when translation
elongation is inhibited by cycloheximide.
Proteasome mutants, ump1-2 and pre4-2, that
bypass essential Rpm2p function, also stabilize
P bodies. The stabilization of P bodies by Rpm2p
may occur through reduced protein degradation
since GFP-Rpm2p expressing cells have lower
levels of ubiquitin. Genetic analysis revealed that
overexpression of Dhh1p (a DEAD box helicase
localized to P bodies) suppresses temperature-
sensitive growth of the rpm2-100 mutant.
Overexpression of Pab1p (a poly (A)-binding protein)
also suppresses rpm2-100, suggesting that
Rpm2p functions in at least two aspects of mRNA
metabolism. The results presented here, and the
transcriptional activation function demonstrated
earlier, implicate Rpm2p as a coordinator of
transcription and mRNA storage/decay in P bodies.
INTRODUCTION
RPM2 is a nuclear gene encoding a multifunctional
protein that can localize to both mitochondria and the
nucleus. Together with the mitochondrially encoded RNA
subunit, Rpm1r, Rpm2p functions as a protein subunit of
mitochondrial RNAse P (1–4). Rpm2p is also required for
the maturation of the RNase P RNA subunit, Rpm1r (5),
and separate domains of Rpm2p promote tRNA and
Rpm1r maturation (6). Analysis of the rpm2-100 mutant
revealed that Rpm2p has a role, independent of RNase P
activity, in translation of mitochondrially encoded cyto-
chrome c oxidase subunits Cox1p, Cox2p and Cox3p (7).
In addition, a synthetic lethal interaction has been
found between the rpm2-100 mutant and the loss of
wild-type mitochondrial DNA (mtDNA). Cells with
either the rpm2-100 mutation or a deletion of mtDNA
grow on glucose, but when both alterations occur in the
same cell there is no growth on any carbon source (7).
Recently, we demonstrated that Rpm2p can localize
to the nucleus, has a transcriptional activation domain,
and plays a role in deﬁning steady-state levels of mRNAs
for some nuclear-encoded mitochondrial components,
such as the TOM complex and the mitochondrial
heat-shock proteins, such as Hsp60p and Hsp10p (8).
It is likely that induction of the TOM components
and the essential chaperones in cells lacking mtDNA is
an adaptation to maintain eﬃcient protein import upon
reduction in membrane potential caused by the loss of
mtDNA. Therefore, Rpm2p has emerged as a regulatory
protein critical to maintaining viability in a retrograde
fashion, when cells lose their mitochondrial genome.
This observation may explain why a complete deletion
of RPM2 is lethal in Saccharomyces cerevisiae (9).
Retrograde signaling is a pathway of communication
from mitochondria to the nucleus (for review, see 10).
Four percent of yeast genes reproducibly alter transcript
levels in glucose grown yeast cells devoid of mtDNA (11).
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mtDNA encode proteins involved in mitochondrial
biogenesis and function (11), including those found to be
dependent on Rpm2p (8).
The work presented here demonstrates that Rpm2p can
localize to cytoplasmic processing bodies (P bodies)
and genetically interacts with Dhh1p. In addition, we
show a genetic interaction between Rpm2p and Pab1p.
The presence of Rpm2p at sites of mRNA degradation
and storage, as well as the relationship with Pab1p,
suggest that changes in mRNA stability, in addition to
changes in transcription may play a role in altering
transcript levels in yeast cells devoid of mtDNA.
MATERIALS AND METHODS
Strains, media andreagents
Rich media included 1% Bacto-yeast extract, 2% Bacto-
peptone and 2% glucose (YPD) or 3% glycerol and 2%
ethanol (GE) instead of glucose. Synthetic complete (SC)
media lacking appropriate amino acids for plasmid
retention contained 0.67% Bacto-nitrogen base and
either 2% glucose or 2% galactose. Solid media for
plates included 2% Bacto-agar. Culture media reagents
were Fisher Scientiﬁc or Difco. Yeast strains used in
this study, yVS100 (MATa ade2-1 ade322 his3-11, 15
leu2-3,11 trp1-1 ura3-1 can1-100 rpm2::rpm2-100)
(this study); YMW1 (MATa ade2-1 ade322 his3-11, 15
leu2-3,11 trp1-1 ura3-1 can1-100) (12) and isogenic
mutants (MATa ade2-1 ade322 his3-11, 15 leu2-3,11
trp1-1 ura3-1 can1-100 ump1-2), (MATa ade2-1 ade322
his3-11, 15 leu2-3,11 trp1-1 ura3-1 can1-100
rpm2::kanMX) (13); BY4741 (MATa his3 leu2
lys2 met15 ura3) and isogenic haploid strains
containing LSM1, and XRN1 disruptions generated by
the S. cerevisiae genome deletion project consortium
were obtained from Research Genetics; yRP1358 (MATa
his4-539 leu2-3112 lys2-201 trp1 ura3-52 dcp2::TRP1)
strain containing DCP2 disruption was a gift from Roy
Parker (University of Arizona). The GAL1-regulated yeast
cDNA library in a centromeric shuttle vector was kindly
provided by Anthony Bretscher, Cornell University (14);
the GFP-Rpm2p expressing plasmid was described (8);
the plasmids expressing the Dcp2p-RFP (pRP1155),
the Lsm1p-RFP (pRP1185) and pAD-Dcp2p (pRP1359)
were kindly provided by Roy Parker.
Plasmid construction
For the yeast two-hybrid analysis, a PCR product of the
RPM2 coding region lacking the ﬁrst 41 amino acids was
cloned into the BamHI site of pGBT9. To construct
plasmid expressing GFP-RPM2 under control of RPM2
promoter, RS315-EP-GFP-RPM2, ﬁrst, a PCR product of
the RPM2 promoter region ( 560þ1) was cloned into
XhoI/BamHI sites of pRS316. Second, a PCR product
encoding GFP-RPM2 was obtained from GFP-Rpm2p
expressing plasmid (8) and cloned downstream of the
promoter region into BamHI/SacI sites. The integrity of
a new fusion gene was conﬁrmed by sequencing.
The oligonucleotide sequences are available upon request.
Library screening
To screen for proteins that suppress the rpm2-100 mutant,
the strain yVS100 was transformed with the yeast
S. cerevisiae cDNA library under control of the
GAL1-inducible promoter on a centromeric shuttle
vector. Transformants were plated on synthetic-complete
medium lacking uracil and screened for growth at 378C.
Plasmids from growers at 378C were isolated and tested
again for suppression of the rpm2-100 mutant under
the same conditions.
Protein synthesis assay
Yeast transformants carrying either the DCP2-RFP fusion
gene, or both, DCP2-RFP and GFP-RPM2, on plasmids
were grown in synthetic-complete selective medium
containing glucose. Cultures were shifted to galactose
synthetic medium for 6h to induce GFP-Rpm2p.
After two washes with sterile water, cultures were
incubated in methionine-free medium for 30min, treated
with 100mg of cycloheximide for 30min, (control left
untreated), and an equivalent number of cells were
incubated in the presence of 50mCi of [
35S-]methionine
for 30min. Ten microliters of each sample was spotted on
ﬁlters pretreated with 50% TCA. Dried ﬁlters were boiled
for 5min in 10% TCA, washed twice in 10% TCA, once
in ethanol, dried and subjected to scintillation counting.
Western analysis
Total protein extracts were made using YBB buﬀer
(Q-BIOgene) and glass beads in the presence of
protease inhibitors (Boehringer). Proteins were separated
on a 4–12% Bis-Tris gel (Invitrogen), transferred to an
Immobilon-P membrane (Millipore, Bedford, MA) and
treated with anti-ubiquitin antibodies at 1mg/ml (15).
The aﬃnity-puriﬁed rabbit polyclonal anti-ubiquitin
antibody was a gift from Arthur Haas (Medical College
of Wisconsin). The anti-GFP polyclonal were diluted
1:5000 (Molecular Probes); the anti-Rpm2p antibodies (7)
were used at 1:2000 dilution.
Microscopy
Yeast transformants expressing fusion proteins were
grown to mid-log phase in synthetic-complete medium
lacking appropriate amino acids for plasmid retention.
Cultures were then shifted to galactose-containing
selective medium and grown for either 6h to induce
GFP-Rpm2p synthesis, or cultivated up to 24h to obtain
high-density cultures. Cells were harvested, washed three
times with water and either spotted directly onto glass
slides or ﬁxed before spotting for imaging on a Zeiss
Axioscope 200 microscope. In the cycloheximide treat-
ments, washes also included 100mg/ml of cycloheximide.
RESULTS
Dhh1p and Pab1p overexpression suppresses rpm2-100
temperature-sensitive growth
Previous studies have showed that the rpm2-100 mutation
causes loss of cell osmotic integrity at the non-permissive
1302 Nucleic Acids Research, 2007, Vol. 35, No. 4temperature, and this phenotype can be suppressed by
increasing osmolarity of the growth medium (Stribinskis
et al., manuscript in preparation). We have used this
temperature-sensitive growth phenotype to isolate high-
copy suppressors that allow rpm2-100 mutant cells to
grow at the restrictive temperature. The yeast S. cerevisiae
cDNA library under control of the GAL1-regulated
promoter (14) was introduced into rpm2-100 cells;
transformants were plated on synthetic plates containing
galactose as the sole carbon source and incubated at 378C.
The screen revealed that in addition to Rpm2p, Dhh1p, an
RNA helicase (16) and Pab1p, poly (A)-binding protein
(17,18), are high-copy suppressors of rpm2-100 tempera-
ture-sensitive growth (Figure 1). Interestingly, PAB1 was
found as a high-copy suppressor of an rpm2 deletion strain
in an independent genetic screen (Nancy C. Martin,
personal communication). Pab1 is a multifunctional
protein that plays a role in stabilization of mRNAs,
brings the 50 and 30 ends of mRNAs into proximity by
binding eIF4G, and stimulates translation (19–21). In
addition, recent observations demonstrate a role for
Pab1p in mRNA export from the nucleus (22,23).
Unlike PAB1 and SEF1 (24), overexpression of DHH1
does not compensate for the rpm2 deletion (data not
shown). Dhh1p belongs to the family of DEAD-box
proteins, which are ATP-dependent RNA helicases found
in a variety of organisms (25). DHH1 was identiﬁed
as a high-copy suppressor of the POP2 and CCR4
transcriptional complex and physically and functionally
associates with Pop2p and Ccr4p (26). In addition,
Dhh1p can stimulate decapping (27,28), and recent
evidence indicates a role for Dhh1p in translational
repression at an early step in mRNA decay (29).
Overexpression of Dhh1p inhibits cell growth (29);
however, as we show here, it has no appreciable inhibitory
eﬀect on cells of YMW (the derivative of W303) genetic
background (Figure 1).
The ﬁnding that overexpression of DHH1 and PAB1
can suppress temperature-sensitive growth of the
rpm2-100 mutant strongly suggests that Rpm2p functions
in some aspects of RNA metabolism outside the
mitochondria.
Rpm2pinteracts withDcp2p in vivo
In a systematic analysis of protein complexes in yeast,
Rpm2p was found in the same complex with Dcp2p by
aﬃnity capture using Dcp2p as bait in two independent
attempts (30,31). Dcp2p is a subunit of the decapping
enzyme and can be found in cytoplasmic processing bodies
(32,31). To determine whether Rpm2p and Dcp2p interact
in vivo, we performed the yeast two-hybrid analysis using
Rpm2p as bait. We employed a reporter gene, HIS3,
which is under control of the yeast GAL DNA-binding
domain. To make the bait, we fused the RPM2 coding
region lacking the ﬁrst 41 amino acids downstream of
the GAL DNA-binding domain (BD-Rpm2p). We intro-
duced this plasmid into a reporter strain together with
another plasmid expressing either Dcp2p fused to the
GAL DNA-activation domain (AD-Dcp2p) or GAL
DNA-activation domain alone (AD). Transformants
were spotted on selective plates and scored for the ability
to grow on medium lacking histidine and containing
3-aminotriazole (AT), a competitive inhibitor of the HIS3
gene product. Figure 2 shows that cells expressing
both the AD-Dcp2p and BD can grow on medium
Vector
RPM2 DHH1
PAB1
PAB1 Vector
DHH1 RPM2
37°C
30°C
SGal-URA
Figure 1. Growth of rpm2-100 strains. The rpm2-100 transformants
carrying either RPM2, DHH1 or PAB1 genes under expression of
GAL1 promoter or vector alone were plated on synthetic plates
containing galactose and scored for growth at 30 and 378C.
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-Trp-Leu-His
1 mM AT
5 mM AT
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BD+AD-Dcp2p
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Figure 2. Rpm2p interacts with Dcp2p in the yeast two-hybrid assay.
Yeast CG1945 strains expressing the combination Gal4p BD alone or
fusion, and Gal4p AD alone or fusion were spotted on SD-Trp-Leu
and SD-Trp-Leu-His (in the absence or presence of aminotriazole, AT)
plates and incubated until visible colonies were formed.
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1mM AT. This background growth is likely attributed
to the leaky expression of the HIS3 gene. Cells expressing
BD-Rpm2p and AD could grow in the presence of 1mM
AT, however their growth was diminished in the presence
of 10mM AT and completely abolished at 15mM AT.
This is because Rpm2p itself has a transactivation
domain containing two putative leucine zippers, and
shows robust reporter activity in the absence of the
carboxy-terminal domain, which is not required for
growth by fermentation (8). However, in the presence of
an intact carboxy-terminus in the construct used here,
Rpm2p transactivation is moderate and can be abolished
at lower concentrations of AT than used in a previous
study (8). In contrast, cells expressing both, BD-Rpm2p
and AD-Dcp2p show increased ﬁtness compared to cells
expressing BD-Rpm2p and AD, at all concentrations of
AT tested. This result indicates that Rpm2p and Dcp2p
can interact in vivo and substantiates a model that
assigned Rpm2p as the attachment protein together
with Xrn1p (a 50 to 30 exonuclease) and a protein of
unknown function, Ybr094p, to a module (Edc3p-Dcp1p-
Dcp2p) known as the mRNA-decapping complex
(Gavin et al. (36)).
Rpm2pcolocalizes withDcp2p in cytoplasmic
processing bodies invivo
We found that the essential portion of Rpm2p, which
can also support mitochondrial RNase P activity under
respiratory growth conditions (6), expressed as a fusion
protein with GFP, concentrates in the nucleus and
localizes to distinct foci in the cytoplasm that did not
appear to colocalize with any organelle (8). The observa-
tion that Rpm2p interacts with Dcp2p, which resides in
cytoplasmic mRNA processing bodies, P bodies (33),
suggested that these foci might be P bodies. DCP2 is an
essential gene, however, yeast strain yRP1358 has an
unknown genetic variation that allows the dcp2
mutant to grow, albeit poorly at all temperatures (32).
To determine whether Rpm2p colocalizes with Dcp2p, the
yeast strain yRP1358 was transformed with GFP-RPM2
and DCP2-RFP constructs and their localization after
induced expression of GFP-Rpm2p with galactose was
determined by ﬂuorescence microscopy. Both proteins
colocalize in discrete cytoplasmic foci, and colocalization
occurs in all cells that have both, green and red
ﬂuorescence (Figure 3A). In addition, overexpression
of GFP-Rpm2p from a powerful, galactose-inducible
promoter, neither leads to an increase in P body size nor
number. The same result was also obtained in two other
widely used laboratory yeast strains W303 and BY4741
(not shown). Therefore, Rpm2p, lacking a mitochondrial
leader sequence, but able to support the essential function,
localizes to P bodies.
Since Rpm2p interacts with Dcp2p, it was important
to determine whether localization of Rpm2p depends
on its interaction with Dcp2p. To address this question,
yRP1358 cells lacking endogenous Dcp2p were cotrans-
formed with plasmids expressing GFP-Rpm2p and
Lsm1p-RFP, and the transformants examined by
ﬂuorescence microscopy. Lsm1p is a component of
P bodies and forms a heteroheptameric complex with
Lsm2-Lsm7 proteins, which is involved in mRNA
deadenylation-dependent decapping (34). Surprisingly,
we could not observe P bodies in the vast majority of
cells lacking Dcp2 protein, even after prolonged incuba-
tion in water, which is known to promote formation of
P bodies (33). This result indicates that Dcp2 protein is
necessary for P body formation in the majority of cells.
However, in a small fraction of cells that contained
P bodies, as visualized using Lsm1p-RFP, GFP-Rpm2p
is present in a P body (Figure 3B). This result indicates
that localization of Rpm2p to P bodies does not require
Dcp2p, at least in a small fraction of cells that contain
P bodies.
Overexpression ofGFP-Rpm2p prevents dissociation
of Pbodies upon inhibition of translation elongation
To determine whether association of Rpm2p with P bodies
remains under conditions that promote dissociation
of other known P body components, cells were exposed
for 30min to cycloheximide (100mg/ml), an inhibitor
of translation elongation. Cycloheximide induces dissocia-
tion of P bodies in both yeast and mammalian cells
(33,35). Figure 4 shows that the typical localization of
Dcp2p-RFP to P bodies is not observed after cyclo-
heximide treatment. In contrast, Dcp2p-RFP remains in
P bodies upon expression of GFP-Rpm2 protein in the
presence of cycloheximide. Moreover, both proteins
remain in P bodies under these conditions. We also
examined whether the observed eﬀect of Rpm2p on P
body stability depends on the stage of growth of a yeast
culture. We found that at each stage of growth, from
OD600¼0.5 (early-log phase) to OD600¼4.0 (end of log
phase), both Dcp2p and Rpm2p ﬂuorescent-tagged
fusions were present in P bodies after cycloheximide
Dcp2p-RFP GFP-Rpm2p Merge
Lsm1p-RFP GFP-Rpm2p
A
B GFP-Rpm2p Merge Merge Lsm1p-RFP
dcp2
dcp2 wt
Figure 3. Rpm2p and Dcp2p colocalize to P bodies. Cells carrying both
GFP-RPM2 and DCP2-RFP in dcp2 strain (A); and GFP-RPM2 and
LSM1-RFP in either wt or dcp2 strain (B), were grown in selective
medium in the presence of galactose for 6h, ﬁxed and ﬂuorescence
determined using microscope.
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GFP-Rpm2p from an inducible GAL promoter stabilizes
P bodies against dissociation by cycloheximide.
One explanation for the Rpm2p eﬀects on P bodies
is that cells become resistant to cycloheximide. To test
this prediction, protein synthesis levels before and
after cycloheximide exposure in cells expressing either
Dcp2p-RFP or both, Dcp2p-RFP and GFP-Rpm2p were
measured. Both strains displayed comparable growth rates
in synthetic galactose medium (310min and 330min
division rates for Dcp2p-RFP and Dcp2-RFP/GFP-
Rpm2p expressing strains, respectively). Although, the
protein synthesis rate in the Dcp2p-RFP/GFP-Rpm2p
strain is reduced by 20% compared to Dcp2p-RFP strain,
the remaining protein synthesis in the presence of
cycloheximide is reduced to the same extent in both
strains indicating that overexpression of Rpm2p does
not desensitize cells to cycloheximide (Figure 5).
Proteasome mutants affect Pbodies
In addition to its role in the mitochondrial RNase P,
Rpm2p is an essential protein under all growth conditions.
It has previously been found that reduced proteasome
activity in pre4-2 or ump1-2 mutants allows growth in
the absence of Rpm2p, although the mechanism is
unknown (13). Therefore, Rpm2p may have a role in
controlling activity of the ubiquitin-proteasome pathway
or the stability of a critical component of the P body
that is rapidly degraded upon inhibition of translation
elongation. If this were true, inhibition of proteasome
activity should stabilize P bodies. To test this hypothesis,
P body formation was determined in a wild-type strain
expressing Dcp2p-RFP or in a strain carrying a mutation
in the proteasome chaperone Ump1p, or in a strain
lacking Rpm2p, but carrying a mutation in the protea-
some catalytic subunit Pre4p, and determined P body
formation. Note that these strains are in YMW genetic
background, in which the essential function of Rpm2p can
be suppressed by proteasome mutants (13). We made
several observations (Figure 6). First, some P bodies are
substantially larger in proteasome mutants compared to
wild-type cells under normal growth conditions, indicating
that the proteasome impacts the size of P body. Second,
inhibition of translation elongation with cycloheximide
does not eliminate P bodies in a majority of cells
containing either proteasome mutant. Third, P bodies
are present in the absence of Rpm2p, suggesting that
Rpm2p itself is not required for the formation of P bodies,
at least under conditions when proteasome activity is
reduced. Together these results provide, for the ﬁrst time,
a link between proteasome function and P bodies.
Lower ubiquitinlevels in cells overexpressing GFP-Rpm2p
Protein degradation by the ubiquitin-proteasome pathway
is required for altering the levels of key regulators, as well
as the degradation of misfolded and mutant proteins.
Attachment of ubiquitin to proteins targets them to the
26S proteasome for degradation. The accumulation
of high-molecular mass ubiquitinated proteins is a
hallmark of reduced proteasome function. To establish
a relationship between Rpm2p and the ubiquitin-
proteasome pathway we examined the levels of
ubiquitinated proteins by comparing cells expressing
GFP-Rpm2p to those that do not. Total protein was
isolated from mid-log phase grown cultures and Western
A600 
0.5
1.0
4.0
Dcp2p-RFP GFP-Rpm2p and Dcp2p-RFP
CHX − ++ + +
Figure 4. Disassembly of P bodies by translational inhibitor cyclohex-
imide (CHX) does not occur in cells overexpressing GFP-Rpm2p.
Cells expressing either Dcp2p-RFP or both, Dcp2p-RFP and GFP-
Rpm2p were grown in galactose synthetic medium and P bodies
visualized at diﬀerent cell culture densities after incubation with or
without CHX for 30min. The diﬀerent cell densities at A600 are
indicated at the right side. For observation, cells were washed three
times in water with or without cycloheximide without ﬁxation.
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Figure 5. Inhibition of protein synthesis by cycloheximide. Equal
numbers of mid-log phase cells, expressing either Dcp2p-RFP or both
Dcp2p-RFP and GFP-Rpm2p, pretreated for 30min with 100mg/ml
cycloheximide, were incubated with
35S-labeled methionine for 30min,
without (open bars) or with (black bars) cycloheximide pretreatment
for 30min. TCA-insoluble material was measured by scintillation
counting. Columns represent an average mean of the representative
experiment performed in triplicate of three biological samples.
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The results show no diﬀerences in the intensity of
a diﬀused signal in the molecular mass range of
30–100kDa, which reﬂects steady-state levels of ubiquiti-
nated proteins, in either strain (Figure 7A). However,
levels of free ubiquitin were reduced in cells expressing
GFP-Rpm2p. To determine if overexpressed Rpm2p
is using up the free ubiquitin for its own turnover,
we reprobed the same membrane with anti-GFP anti-
bodies and found no evidence for the accumulation of
higher molecular mass GFP-Rpm2p species. Although the
mechanism of the ubiquitin depletion in GFP-Rpm2p
expressing cells is unclear, it is possible that depletion
in free ubiquitin levels may reduce the availability of
ubiquitin for conjugation and this reduction contributes to
increased stability of some proteins involved in P body
formation and/or maintenance.
GFP-Rpm2plocalizes toPbodies when expressed
atnormal levels
To determine whether localization of Rpm2p to P bodies is
due to overexpression of the fusion protein, or is an
intrinsic property of Rpm2p, we performed localization
studiesunderconditionswhereafusionproteinisexpressed
at levels comparable to the endogenous levels of Rpm2p.
In the ﬁrst approach, cells expressing both the Dcp2p-RFP
and GAL promoter-driven GFP-Rpm2p were grown on
a fermentable, but not repressible, carbon source raﬃnose
in the BY4741 yeast. We switched to the BY4741 strain
because the yRP1358 strain, used in previous experiments,
hasleakyexpressionfromtheGALpromoterintheabsence
of galactose (not shown). We monitored the kinetics
of GFP-Rpm2p localization after addition of galactose.
Figure 8 demonstrates that GFP-Rpm2p is undetectable
in extracts prepared from BY4741 cells grown in raﬃnose
medium. However, its expression is induced after 20min
upon galactose addition, and the level of expression
continues to rise up to 4h. We found that when expression
of GFP-Rpm2p reaches comparable levels to that of
endogenous Rpm2p (20min after galactose addition)
(panel A), the fusion protein localizes together with
Dcp2-RFP in cytoplasmic foci (panel B), indicating the
rapid kinetics of Rpm2p localization to P bodies.
In the second approach, we constructed a plasmid
where the expression of GFP-Rpm2p is under control of
RPM2 promoter. The transformants in BY4741 genetic
background, harboring both GFP-RPM2 and DCP2-RFP
fusion genes on centromeric plasmids, were grown
in selective raﬃnose medium, ﬁxed and subjected to
ﬂuorescent microscopy. Figure 9 shows that GFP-Rpm2p
expressed from a centromeric plasmid under control
of the RPM2 promoter, colocalizes with Dcp2p-RFP.
Together, these results indicate that localization of Rpm2p
to P bodies is not a consequence of protein overproduc-
tion, and occurs when Rpm2p is not targeted to the
mitochondria.
RPM2/ump1-2
wt
∆rpm2/pre4-2
CHX  − +
Relevant genotype
Figure 6. P bodies are aﬀected by proteasome mutants. The wild-type
strain, a strain carrying a mutation in UMP1, and a strain lacking
RPM2 but carrying a mutation in the PRE4 all expressing Dcp2p-RFP
were grown in glucose synthetic medium and P bodies visualized before
and after incubation with cycloheximide for 30min.
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Figure 7. Depletion of ubiquitin in cells expressing GFP-Rpm2p.
(A) Cells expressing either Dcp2p-RFP or Dcp2p-RFP and GFP-
Rpm2p were grown in synthetic galactose medium in the exponential
phase, and total protein extracts were analyzed by Western analysis
with anti-ubiquitin antibodies after gel-separation and transfer to the
membrane. Increasing amounts of protein extracts were used: 2mg,
lanes 1 and 2; 4mg, lanes 3 and 4; 8mg, lanes 5 and 6.  , unknown
protein recognized by anti-ubiquitin antibodies serves as a loading
control. A part of the membrane where free ubiquitin is detected was
underexposed (bottom panel). (B) The same membrane was reprobed
with anti-GFP antibodies.
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an inducible GAL promoter stabilizes P bodies against
dissociation by cycloheximide (Figure 4). Although under
conditions where Rpm2p protein levels are very high it
was unclear whether the presence of Rpm2p in P bodies
or the high levels of expression stabilize P bodies.
To determine whether stabilization of P bodies against
cycloheximide can occur when fusion protein is expressed
under an endogenous RPM2 promoter, we exposed cells
for 30min to cycloheximide (100mg/ml) in growth
medium. Figure 9 shows that the typical localization
of both Dcp2p-RFP and GFP-Rpm2p to discrete
cytoplasmic foci is not observed after cycloheximide
treatment, indicating that the presence of GFP-Rpm2p
in P bodies is not suﬃcient to prevent dissociation of
P bodies by cycloheximide.
To determine other requirements for Rpm2p localiza-
tion to P bodies, we transformed GFP-Rpm2p expressing
plasmid under control of the RPM2 promoter into lsm1
and xrn1 deletion strains (BY4741 background),
lacking individual components of P bodies. We found
that GFP-Rpm2p colocalizes with Dcp2p-RFP in
P bodies in both mutants. This result indicates that
defects in either decapping (lsm1 cells) or the 50 to
30 mRNA degradation (xrn1 cells) do not aﬀect the
association of Rpm2p with P bodies.
DISCUSSION
This work presents evidence that Rpm2p localizes
to cytoplasmic processing bodies. Moreover, we found
that overexpression of Dhh1p, a known component of
P bodies, in addition to Pab1p, a poly (A)-binding protein,
suppresses temperature-sensitive growth of the rpm2-100
mutant. These data indicate that Rpm2p has a role in
cytoplasmic mRNA metabolism, in addition to its role in
tRNA processing inside the mitochondria.
P bodies have been described both in yeast and
mammalian cells. They contain the decapping enzyme
composed of Dcp1p and Dcp2p, the conserved 50-30
exonuclease Xrn1p, the Sm-like proteins Lsm1-Lsm7,
the deadenylase hCcr4, the helicase Dhh1p, the enhancer
of decapping Edc3p, Pat1p, the translational repressor, in
addition to mRNAs associated with P bodies (33,36–38).
In addition, in mammalian cells, P bodies contain
components of the silencing complex, such as
microRNAs and argonaute protein (39,40), the eIF4E-
binding protein 4-ET, three autoantigens, GW182, Ge-1
and RAP55 (41–43), and several RNA-binding proteins
including TTP, BRF1, and CPEB (44). The mRNAs
associated with P bodies are not actively involved in
translation; however, they are required for the assembly
Rpm2p
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Figure 8. Kinetics of the induction and localization of GFP-
Rpm2p fusion protein. (A) Western analysis of GFP-Rpm2p fusion
protein before and after addition of galactose. The protein was detected
using both anti-GFP and Rpm2p antibodies. Rpm2p shows the
migration of endogenous Rpm2p. X, unknown protein recognized by
anti-Rpm2p antibodies serving as a loading control. (B) Kinetics of
GFP-Rpm2p colocalization with Dcp2p-RFP before and after addition
of galactose.
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Figure 9. GFP-Rpm2p localization when expressed from its endo-
genous promoter. GFP-Rpm2p is observed in P bodies in the absence
but not the presence of cycloheximide (CHX) (two upper panels).
Localization of GFP-Rpm2p to P bodies does not require Lsm1p
or Xrn1p, other components of P bodies (two bottom panels).
The Dcp2p-RFP was used as a P body marker in colocalization studies.
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mRNA decapping and degradation can occur, since
mRNA decay intermediates, when trapped during degra-
dation, are localized in P bodies (33). In addition,
the formation of a P body is important for control of
translational repression (29). The movement of mRNA
from P bodies to the polysomes has been documented
recently (46), indicating that P bodies are dynamic sites
where mRNA can be either degraded or stored until
appropriate conditions allow translation to resume.
Although we recently demonstrated that Rpm2p acts
as transcriptional activator in the nucleus when not
targeted to the mitochondria (9), the presence of Rpm2p
in P bodies invokes a role in mRNA remodeling in the
cytoplasm. Therefore, Rpm2p may function to coordinate
transcription and mRNA decay. Several observations
indicate that Rpm2p may directly interact with Dcp2p,
a catalytic subunit of the decapping enzyme in P bodies.
First, Rpm2p interacts with Dcp2p in aﬃnity capture
experiments (30,31). Second, as shown here, Rpm2p
interacts with Dcp2p in the yeast two-hybrid system.
Third, overexpression of Dhh1p, a component of P bodies
that can regulate mRNA decapping (27,28), suppresses
temperature-sensitive growth of the rpm2-100 mutant.
DCP2 (formerly known as PSU1) was originally
identiﬁed as a suppressor of a nuclear petite mutant
(petite mutants do not grow by respiration) (Tzagoloﬀ,
GenBank, accession #L43065). Later reports revealed that
a variety of mutants defective in decapping also show
respiratory growth defects. Cells that lack Dcp1p, a major
component of decapping enzyme, do not grow by
respiration at any temperature, but do grow by fermenta-
tion (47). The mutants lacking either DHH1 or EDC1 that
stimulate mRNA decapping, also have defects in respira-
tory growth (47,26). These observations suggest that
mRNA remodeling through decapping is necessary for
growth on respiratory carbon sources. Two diﬀerent
RPM2 mutants, rpm2-C and rpm2-100 described
previously (6,7) have defects in the utilization of non-
fermentable carbon sources. The rpm2-100 cells maintain
normal mitochondrial RNase P activity but grow extreme-
ly slowly on respiratory medium, due to a defect in the
translation of all three mitochondrially encoded subunits
of cytochrome c oxidase (7). The rpm2-C mutant has a
very peculiar property. If the C mutation is introduced
into cells that are grown on glucose, the cells lose
mitochondrial DNA at a very high frequency and
subsequently cannot grow by respiration. However,
if the mutation is introduced into cells during respiratory
growth, the cells continue to respire, albeit slowly due
to defects in the processing of RNA subunit of mitochon-
drial RNase P (6), indicating that the loss of mtDNA
is conditional and depends on the carbon source.
Therefore, if Rpm2p has a role in mRNA decapping,
it might aﬀect decapping under diﬀerent growth condi-
tions. Alternatively, Rpm2p may control decapping
of speciﬁc mRNAs that are essential during a switch
from a fermentable to non-fermentable carbon source.
In addition, the same activity of Rpm2p may play a role
in adaptation to high temperature and other stresses.
For instance, the rpm2-100 mutant cells cannot withstand
high temperatures (Figure 1), and cannot tolerate loss
of mtDNA (7) but wild-type cells can lose mtDNA and
are more resistant to diﬀerent stresses, including high
temperature (11).
We cannot exclude the possibility that Rpm2p possesses
some nuclease activity in P bodies by itself or in combi-
nation with either protein or RNA, since in the
mitochondria it functions as an endonuclease together
with Rpm1r, the RNA subunit (2). Many eukaryotic
mRNAs can be degraded by endonucleolytic cleavage
(for references, see review in 48). In addition, RNA-
mediated gene silencing involves endonucleolytic cleavage
(for review, see 49), and can occur in P bodies in
mammalian cells (39,40).
The ﬁndings that Rpm2p can localize to P bodies and
the isolation of PAB1 and DHH1 genes as high-copy
suppressors of rpm2-100 suggest diﬀerent roles for Rpm2p
in RNA metabolism. It is surprising that two proteins
apparently performing opposite functions in the cell can
suppress rpm2-100 when overexpressed. In contrast to
Pab1p, which stimulates translation complex assembly,
Dhh1p promotes recruitment of mRNA to a repressed
state (29). However, under certain stresses the human
homolog of Dhh1p, rck/p54, localizes to stress granules,
the cytoplasmic foci where translation preinitiation
complexes assemble on mRNA and accumulate with
various mRNA-binding proteins, including Pab1p (50,35).
These observations suggest that under some conditions
both Dhh1p and Pab1p participate in translational
silencing and mRNA storage. Although stress granule
formation was not reported in the yeast S. cerevisiae,
similar structures containing translation initiation
complex eIF3 were found in the ﬁssion yeast
Schizosaccharomyces pombe (51).
While both Dhh1p and Pab1p are involved in
translational control, only overexpression of Pab1p
suppresses the rpm2 deletion (personal communication).
Pab1p participates in many aspects of mRNA metabolism
such as 30 end processing, translation and decay (52–56).
Translational enhancement by Pab1p is mediated by the
binding of Pab1p to initiation factor eIF4G, which is a
part of the mRNA cap-binding complex eIF4F (19).
Binding of Pab1p stabilizes mRNA in a translation-
dependent manner (56), and mutations in either the PAB1
or IF4F complex lead to destabilization of mRNA (57,58).
Recent observations show that Pab1p rapidly shuttles
between the nucleus and the cytoplasm and is required for
the eﬃcient export of mRNA out of the nucleus (22,23).
Since Rpm2p has RNA-binding activity and can localize
to the nucleus and the cytoplasm, it may also have a role
in mRNA export and assembly of mRNPs into P bodies.
The most interesting ﬁnding was that overexpression
of GFP-Rpm2p prevents the disappearance of P bodies
that occurs when translation elongation is inhibited by
cycloheximide. This eﬀect is independent of the growth
stage because it was observed in cultures at both low
and high cell densities. Usually all known components
of P bodies dissociate upon cycloheximide treatment
in both yeast and mammalian cells (33,35,45). Yeast
P bodies contain mRNAs in equilibrium with polysomes
and cycloheximide treatment, which prevents mRNAs
1308 Nucleic Acids Research, 2007, Vol. 35, No. 4from exiting translation and entering P bodies, leads to the
disappearance of P bodies (46). In contrast, inhibition
of translation initiation by genetic means in yeast or
by silencing in mammalian cells, results in increase in
P bodies (33,45,29,35,36). For instance, overexpression
of translational repressors, such as Dhh1p and Pat1p from
an inducible galactose promoter represses translation,
promotes dissociation of mRNA from polysomes and
facilitates assembly of mRNAs into P bodies (29).
This leads to a dramatic increase in P body abundance.
However, overexpression of GFP-Rpm2p under the same
conditions (expression from a galactose-inducible promo-
ter in the same yeast genetic background used in the study
by Coller and Parker (29)) does not impact the number
and size of P bodies (Figure 2), arguing against a role for
Rpm2p in translational repression, and suggesting that
stabilization of P bodies against cycloheximide treatment
involves some other mechanism. Since Rpm2p is also
nuclear, it is plausible that Rpm2p may have a role in the
increased ﬂow of mRNAs directly to P bodies before
mRNAs enter the translation apparatus. If this were true,
stabilization of P bodies could occur, independent of those
mRNAs that are trapped on polysomes upon cyclo-
heximide treatment.
Evidence is also presented here that cells expressing
GFP-Rpm2p have lower ubiquitin levels. Ubiquitin levels
are important for a proper balance between all ubiquitin-
dependent processes, and analysis of ubiquitin proﬁles in
a variety of yeast proteasome mutants suggests the
existence of a homeostatic mechanism that maintains
free ubiquitin levels within a certain range (59). A decrease
in ubiquitin levels to about half of the wild-type level,
compromises degradation of all substrates tested (59,60).
Although the mechanism of the ubiquitin depletion
in GFP-Rpm2p-expressing cells is unclear, it is possible
that depletion in free ubiquitin levels may reduce the
availability of ubiquitin for conjugation and this reduction
contributes to increased stability of some proteins
involved in P body formation and/or maintenance.
Consistent with this, we found that proteasome mutants,
ump1-2 and pre4-2, which are defective either in protea-
some maturation or function, respectively, stabilize
P bodies under conditions where all known components
dissociate from P bodies. Moreover, P bodies appear
larger in proteasome mutants compared to wild-type
under normal growth conditions. These observations,
combined with previous work which demonstrated that
the essential role of Rpm2p can be bypassed by inhibiting
proteasome function (13), strongly argues for a genetic
interaction amongst Rpm2p, the ubiquitin-proteasome
pathway and P bodies.
This study identiﬁed Rpm2p as a new component of
P bodies. It is clear that Rpm2p has RNA-binding activity
and therefore such binding activity may be important
for its P body function. The observation that Rpm2p
localizes to the nucleus and activates gene expression (9)
coupled with its presence in P bodies, suggests that Rpm2p
may provide a link between mRNA transcription
and turnover/storage. The connection reported between
proteasome function and P bodies implies that inhibition
of proteasome activity may change the abundance of
some mRNAs post-transcriptionally, due to changes in
the stability of P bodies. If the same holds for mammalian
cells, this may be of medical relevance since proteasome
inhibitors are being tested and used in anticancer
therapy (61).
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